These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34221906)

  • 1. The Burden of HIV, Hepatitis B and Hepatitis C by Armed Conflict Setting: The Nigeria AIDS Indicator and Impact Survey, 2018.
    Aliyu GG; Aliyu SH; Ehoche A; Dongarwar D; Yusuf RA; Aliyu MH; Salihu HM
    Ann Glob Health; 2021 Jun; 87(1):53. PubMed ID: 34221906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-hepatitis co-infection in a rural community in Northern Nigeria.
    Adesegun OA; Olaniran OH; Bamidele E; Inyang JN; Adegbe M; Binuyo TO; Ehioghae O; Adeyemi O; Oyebisi O; Idowu AO; Ajose O
    Pan Afr Med J; 2020; 36():352. PubMed ID: 33224418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
    Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
    BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, seroconversion and mother-to-child transmission of dual and triplex infections of HIV, hepatitis B and C viruses among pregnant women in Nigeria: study protocol.
    Eleje GU; Mbachu II; Ogwaluonye UC; Kalu SO; Onubogu CU; Nweje SI; Uzochukwu CE; Nwankwo CH; Fiebai PO; Loto OM; Akaba GO; Usman HA; Rabiu A; Egeonu RO; Igue OE; Adesoji BA; Jibuaku CH; Aja PO; Chidozie CP; Ibrahim HS; Aliyu FE; Numan AI; Okoro OD; Omoruyi SA; Oppah IC; Anyang UI; Ahmed A; Chukwurah SN; Umeononihu OS; Chukwuanukwu RC; Umeh EO; Emeka EA; Ogbuagu CN; Yakasai IA; Ezechi OC; Ikechebelu JI;
    Reprod Health; 2020 Sep; 17(1):144. PubMed ID: 32977846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt.
    el-Sayed NM; Gomatos PJ; Rodier GR; Wierzba TF; Darwish A; Khashaba S; Arthur RR
    Am J Trop Med Hyg; 1996 Aug; 55(2):179-84. PubMed ID: 8780457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria.
    Tun W; Vu L; Adebajo SB; Abiodun L; Sheehy M; Karlyn A; Njab J; Ahonsi B; Issa BK; Idogho O
    Int J STD AIDS; 2013 Aug; 24(8):619-25. PubMed ID: 23970571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
    Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE
    J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S; Mahmoodi MF; Andalibi S; Solati AA
    J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.
    Santana Rodríguez OE; Malé Gil ML; HernándezSantana JF; Limiñana Cañal JM; Martín Sánchez AM
    Eur J Epidemiol; 1998 Sep; 14(6):555-61. PubMed ID: 9794122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria.
    Adoga MP; Banwat EB; Forbi JC; Nimzing L; Pam CR; Gyar SD; Agabi YA; Agwale SM
    J Infect Dev Ctries; 2009 Aug; 3(7):539-47. PubMed ID: 19762972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coinfection with hepatitis B and C viruses among HIV positive pregnant women in Enugu south east, Nigeria.
    Okeke TC; Obi SN; Okezie OA; Ugwu EO; Akogu SP; Ocheni S; Ezenyeaku CC
    Niger J Med; 2012; 21(1):57-60. PubMed ID: 23301449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-infections of hepatitis B and C with human immunodeficiency virus among adult patients attending human immunodeficiency virus outpatients clinic in Benin City, Nigeria.
    Ojide CK; Kalu EI; Ogbaini-Emevon E; Nwadike VU
    Niger J Clin Pract; 2015; 18(4):516-21. PubMed ID: 25966725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.
    Otegbayo JA; Taiwo BO; Akingbola TS; Odaibo GN; Adedapo KS; Penugonda S; Adewole IF; Olaleye DO; Murphy R; Kanki P
    Ann Hepatol; 2008; 7(2):152-6. PubMed ID: 18626434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
    Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
    BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran.
    Moradi G; Hajarizadeh B; Rahmani K; Mohamadi-Bolbanabad A; Darvishi S; Zareie B; Zavareh FA; Sharafi H; Alavian SM; Ramazani R; Eftekhar M; Radfar SR; Piroozi B; Gouya MM
    Int J Drug Policy; 2019 Nov; 73():129-134. PubMed ID: 31654935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Hepatitis B Surface Antigen and Antibodies to Hepatitis C in the General Population of Benue State, Central Nigeria.
    Malu AO; Achinge GI; Utoo PM; Kur JT; Obekpa SA
    Am J Trop Med Hyg; 2020 May; 102(5):995-1000. PubMed ID: 32043452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sero-prevalence and factors associated with Hepatitis B and C co-infection in pregnant Nigerian women living with HIV infection.
    Ezechi OC; Kalejaiye OO; Gab-Okafor CV; Oladele DA; Oke BO; Musa ZA; Ekama SO; Ohwodo H; Agahowa E; Gbajabiamilla T; Ezeobi PM; Okwuraiwe A; Audu R RA; Okoye RN; David AN; Odunukwe NN; Onwujekwe DI; Ujah IA
    Pan Afr Med J; 2014; 17():197. PubMed ID: 25396023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B and C virus prevalence and association with demographics: report of population screening in Nigeria.
    Onyekwere CA; Hameed L
    Trop Doct; 2015 Oct; 45(4):231-5. PubMed ID: 25515733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Markers of hepatitis B, C and HIV among orthopedic patients and staff at a Polish university hospital].
    Gańczak M; Bohatyrewicz A; Szych Z; Białecki P
    Chir Narzadow Ruchu Ortop Pol; 2008; 73(2):83-8. PubMed ID: 18846999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual positivity of hepatitis B surface antigen and anti-hepatitis C virus antibody and associated factors among apparently healthy patients of Ekiti State, Nigeria.
    Oje OJ; Sule WF; Famurewa D
    Viral Immunol; 2012 Dec; 25(6):448-55. PubMed ID: 23171358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.